OTCMKTS:SSMXY - Sysmex Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$52.24
▲ +0.57 (1.10%)
1 month | 3 months | 12 months
Get New Sysmex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SSMXY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SSMXY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Sysmex in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $52.24.

Hold

The current consensus among 3 contributing investment analysts is to hold stock in Sysmex.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/12/2021Daiwa Capital MarketsDowngradeOutperform ➝ Neutral
i
11/25/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgradeSell ➝ Neutral
i
11/25/2020Smith Barney CitigroupUpgradeSell ➝ Neutral
i
6/5/2020Daiwa Capital MarketsUpgradeNeutral ➝ Outperform
i
4/16/2020CitigroupDowngradeNeutral ➝ Sell
i
11/26/2019MizuhoDowngradeBuy ➝ Neutral
i
(Data available from 6/14/2016 forward)
Sysmex logo
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Read More

Today's Range

Now: $52.24
$51.90
$52.24

50 Day Range

MA: $50.98
$47.45
$54.65

52 Week Range

Now: $52.24
$35.38
$65.49

Volume

17,000 shs

Average Volume

23,356 shs

Market Capitalization

$21.88 billion

P/E Ratio

69.65

Dividend Yield

0.25%

Beta

0.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Sysmex?

The following Wall Street research analysts have issued research reports on Sysmex in the last year: Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Daiwa Capital Markets, and Smith Barney Citigroup.
View the latest analyst ratings for SSMXY.

What is the current price target for Sysmex?

0 Wall Street analysts have set twelve-month price targets for Sysmex in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sysmex in the next year.
View the latest price targets for SSMXY.

What is the current consensus analyst rating for Sysmex?

Sysmex currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SSMXY, but not buy more shares or sell existing shares.
View the latest ratings for SSMXY.

What other companies compete with Sysmex?

How do I contact Sysmex's investor relations team?

Sysmex's physical mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company's listed phone number is 817-8265-0500. The official website for Sysmex is www.sysmex.co.jp.